CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 4 Grant or award CEO acquired 750,000 shares (grant or award)
- 4 Grant or award CFO acquired 87,500 shares (grant or award)
- 4 Open-market sale CFO sold 21,358 shares at an average $29.47 ($629,382)
- 4 Open-market sale Director sold 5,000 shares at $30.44 ($152,200)
- 4 Open-market sale Director sold 25,000 shares at $30.20 ($754,875)
- 4 Open-market sale Director sold 20,000 shares at $24.48 ($489,600)
- 4 Open-market sale Director sold 25,933 shares at an average $16.69 ($432,889)
- 4 Grant or award Director acquired 22,250 shares (grant or award)
- 4 Grant or award Director acquired 22,250 shares (grant or award)
- 4 Grant or award Director acquired 22,250 shares (grant or award)
- 4 Grant or award Director acquired 22,250 shares (grant or award)
- 4 Open-market sale Director sold 5,000 shares at $15.94 ($79,675)
- 4 Open-market sale Director sold 22,000 shares at $15.97 ($351,340)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Director sold 17,500 shares at $19.03 ($333,025)
- 4 Grant or award CEO acquired 1,001,908 shares (grant or award)
- 4 Open-market sale CFO sold 47,867 shares at $16.91 ($809,431)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
Page 2 of 18 · 353 filings